Feasibility of Virtual Research Visits in Fox Trial Finder
Abstract Background: Fox Trial Finder is an online registry for individuals with and without Parkinson disease (PD) interested in participating in PD research. However, distance or disability could prevent such individuals from participating in traditional, clinic-based research at major centers. Ob...
Saved in:
Published in | Journal of Parkinson's disease Vol. 5; no. 3; pp. 505 - 515 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London, England
SAGE Publications
14.09.2015
IOS Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Background: Fox Trial Finder is an online registry for individuals with and without Parkinson disease (PD) interested in participating in PD research. However, distance or disability could prevent such individuals from participating in traditional, clinic-based research at major centers.
Objective: Use videoconferencing to connect participants to specialists to: (1) demonstrate feasibility of virtual research visits within this population (2) collect phenotypic data of the participants, (3) validate self-reported diagnosis, and (4) gauge interest in virtual research visits.
Methods: We solicited volunteers throughout the United States through Fox Trial Finder. Interested individuals with PD provided consent, were given web cameras if needed, completed baseline surveys, and downloaded videoconferencing software remotely. Participants had a test connection and assessment appointment which included the Montreal Cognitive Assessment (MoCA), then a virtual research visit with a neurologist who reviewed their history and assessed their PD using a modified Movement Disorders Society Unified Parkinson’s Disease Rating Scale. Neurologists assessed PD diagnosis and symptomatology. Physicians and participants were surveyed about their experience.
Results: Of 204 individuals who consented, 166 (81% ) individuals from 39 states completed all visits. The mean age was 62 and mean disease duration was 8.0 years. Mean MoCA score was 26.5, and mean modified MDS-UPDRS motor score was 22.8 (out of a possible 124). Neurologists judged PD as the most likely diagnosis in 97% of cases. Overall satisfaction with the visits was 79% (satisfied or very satisfied) among neurologists and 93% among participants.
Conclusions: Through virtual research visits, neurologists engaged, characterized, and validated self-reported diagnosis in individuals with PD over a broad geography. This model may facilitate future research participation. |
---|---|
AbstractList | Abstract
Background: Fox Trial Finder is an online registry for individuals with and without Parkinson disease (PD) interested in participating in PD research. However, distance or disability could prevent such individuals from participating in traditional, clinic-based research at major centers.
Objective: Use videoconferencing to connect participants to specialists to: (1) demonstrate feasibility of virtual research visits within this population (2) collect phenotypic data of the participants, (3) validate self-reported diagnosis, and (4) gauge interest in virtual research visits.
Methods: We solicited volunteers throughout the United States through Fox Trial Finder. Interested individuals with PD provided consent, were given web cameras if needed, completed baseline surveys, and downloaded videoconferencing software remotely. Participants had a test connection and assessment appointment which included the Montreal Cognitive Assessment (MoCA), then a virtual research visit with a neurologist who reviewed their history and assessed their PD using a modified Movement Disorders Society Unified Parkinson’s Disease Rating Scale. Neurologists assessed PD diagnosis and symptomatology. Physicians and participants were surveyed about their experience.
Results: Of 204 individuals who consented, 166 (81% ) individuals from 39 states completed all visits. The mean age was 62 and mean disease duration was 8.0 years. Mean MoCA score was 26.5, and mean modified MDS-UPDRS motor score was 22.8 (out of a possible 124). Neurologists judged PD as the most likely diagnosis in 97% of cases. Overall satisfaction with the visits was 79% (satisfied or very satisfied) among neurologists and 93% among participants.
Conclusions: Through virtual research visits, neurologists engaged, characterized, and validated self-reported diagnosis in individuals with PD over a broad geography. This model may facilitate future research participation. Fox Trial Finder is an online registry for individuals with and without Parkinson disease (PD) interested in participating in PD research. However, distance or disability could prevent such individuals from participating in traditional, clinic-based research at major centers. Use videoconferencing to connect participants to specialists to: (1) demonstrate feasibility of virtual research visits within this population (2) collect phenotypic data of the participants, (3) validate self-reported diagnosis, and (4) gauge interest in virtual research visits. We solicited volunteers throughout the United States through Fox Trial Finder. Interested individuals with PD provided consent, were given web cameras if needed, completed baseline surveys, and downloaded videoconferencing software remotely. Participants had a test connection and assessment appointment which included the Montreal Cognitive Assessment (MoCA), then a virtual research visit with a neurologist who reviewed their history and assessed their PD using a modified Movement Disorders Society Unified Parkinson's Disease Rating Scale. Neurologists assessed PD diagnosis and symptomatology. Physicians and participants were surveyed about their experience. Of 204 individuals who consented, 166 (81% ) individuals from 39 states completed all visits. The mean age was 62 and mean disease duration was 8.0 years. Mean MoCA score was 26.5, and mean modified MDS-UPDRS motor score was 22.8 (out of a possible 124). Neurologists judged PD as the most likely diagnosis in 97% of cases. Overall satisfaction with the visits was 79% (satisfied or very satisfied) among neurologists and 93% among participants. Through virtual research visits, neurologists engaged, characterized, and validated self-reported diagnosis in individuals with PD over a broad geography. This model may facilitate future research participation. Background: Fox Trial Finder is an online registry for individuals with and without Parkinson disease (PD) interested in participating in PD research. However, distance or disability could prevent such individuals from participating in traditional, clinic-based research at major centers. Objective: Use videoconferencing to connect participants to specialists to: (1) demonstrate feasibility of virtual research visits within this population (2) collect phenotypic data of the participants, (3) validate self-reported diagnosis, and (4) gauge interest in virtual research visits. Methods: We solicited volunteers throughout the United States through Fox Trial Finder. Interested individuals with PD provided consent, were given web cameras if needed, completed baseline surveys, and downloaded videoconferencing software remotely. Participants had a test connection and assessment appointment which included the Montreal Cognitive Assessment (MoCA), then a virtual research visit with a neurologist who reviewed their history and assessed their PD using a modified Movement Disorders Society Unified Parkinson’s Disease Rating Scale. Neurologists assessed PD diagnosis and symptomatology. Physicians and participants were surveyed about their experience. Results: Of 204 individuals who consented, 166 (81% ) individuals from 39 states completed all visits. The mean age was 62 and mean disease duration was 8.0 years. Mean MoCA score was 26.5, and mean modified MDS-UPDRS motor score was 22.8 (out of a possible 124). Neurologists judged PD as the most likely diagnosis in 97% of cases. Overall satisfaction with the visits was 79% (satisfied or very satisfied) among neurologists and 93% among participants. Conclusions: Through virtual research visits, neurologists engaged, characterized, and validated self-reported diagnosis in individuals with PD over a broad geography. This model may facilitate future research participation. |
Author | Grischkan, Justin Wagner, Joseph D. Achey, Meredith A. Cappelletti, Lily Rocker, Charlotte Rizzieri, Ashley Biemiller, Rachel A. Biglan, Kevin M. Schwarz, Heidi Sherer, Todd Kang, Gail Dorsey, E. Ray Richard, Irene H. Meunier, Claire Ahmad, Stacy H. Chowdhury, Sohini Bull, Michael T. |
Author_xml | – sequence: 1 givenname: E. Ray surname: Dorsey fullname: Dorsey, E. Ray email: ray.dorsey@chet.rochester.edu organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States – sequence: 2 givenname: Joseph D. surname: Wagner fullname: Wagner, Joseph D. organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States – sequence: 3 givenname: Michael T. surname: Bull fullname: Bull, Michael T. organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States – sequence: 4 givenname: Ashley surname: Rizzieri fullname: Rizzieri, Ashley organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States – sequence: 5 givenname: Justin surname: Grischkan fullname: Grischkan, Justin organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States – sequence: 6 givenname: Meredith A. surname: Achey fullname: Achey, Meredith A. organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States – sequence: 7 givenname: Todd surname: Sherer fullname: Sherer, Todd organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States – sequence: 8 givenname: Sohini surname: Chowdhury fullname: Chowdhury, Sohini organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States – sequence: 9 givenname: Claire surname: Meunier fullname: Meunier, Claire organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States – sequence: 10 givenname: Lily surname: Cappelletti fullname: Cappelletti, Lily organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States – sequence: 11 givenname: Charlotte surname: Rocker fullname: Rocker, Charlotte organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States – sequence: 12 givenname: Irene H. surname: Richard fullname: Richard, Irene H. organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States – sequence: 13 givenname: Heidi surname: Schwarz fullname: Schwarz, Heidi organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States – sequence: 14 givenname: Gail surname: Kang fullname: Kang, Gail organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States – sequence: 15 givenname: Stacy H. surname: Ahmad fullname: Ahmad, Stacy H. organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States – sequence: 16 givenname: Rachel A. surname: Biemiller fullname: Biemiller, Rachel A. organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States – sequence: 17 givenname: Kevin M. surname: Biglan fullname: Biglan, Kevin M. organization: Department of Cell Biology and Pathology, Thomas Jefferson University, Philadelphia, PA, United States |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26406130$$D View this record in MEDLINE/PubMed |
BookMark | eNptkN1KwzAYhoNM3Jw78QKkZ4JQTZqmaUEEmdYfBopM8Syk2dcto2tH0om7m13LrsyM6lBZThLyPe_7wXOIWmVVAkLHBJ_TgNKLx-cbnzDMwmQPdUjMuc9J_N7avjlpo561U-wOI5HLHKB2EIU4IhR30GUK0upMF7peelXuvWlTL2ThvYAFadTEfVhdW0-X61Vafa5XQ6PdONXlCMwR2s9lYaH3fXfRa3o77N_7g6e7h_71wFchj2qfRySAMOBRIpkEnAURSKISpoAoDARjUDEeESKBsyzOGIuJDKjKw0wqwnNKu-iq6Z0vshmMFJS1kYWYGz2TZikqqcXfSaknYlx9iDAJKMfcFZz8Ltgmfzw44KwBlKmsNZBvEYLFxrNwnkXj2cH4H6x0LWtdbZbrYnfktIlYOQYxrRamdMJ2kV8sz409 |
CitedBy_id | crossref_primary_10_1017_cts_2022_459 crossref_primary_10_1007_s41347_022_00261_7 crossref_primary_10_1177_1742395316653453 crossref_primary_10_1055_s_0043_1768665 crossref_primary_10_1002_mds_29725 crossref_primary_10_3233_JPD_202249 crossref_primary_10_1038_nrd_2018_133 crossref_primary_10_3233_JPD_202402 crossref_primary_10_3390_geriatrics9030066 crossref_primary_10_1002_mdc3_12665 crossref_primary_10_1002_mds_28991 crossref_primary_10_1016_j_clinthera_2017_03_018 crossref_primary_10_1186_s12883_023_03403_3 crossref_primary_10_3233_JPD_202381 crossref_primary_10_1055_s_0042_1755323 crossref_primary_10_3233_JPD_202163 crossref_primary_10_3233_JPD_202121 crossref_primary_10_1002_acn3_51236 crossref_primary_10_1016_j_pec_2020_12_027 crossref_primary_10_1016_S1474_4422_17_30167_9 crossref_primary_10_1093_ptj_pzz133 crossref_primary_10_2196_53790 crossref_primary_10_2196_54145 crossref_primary_10_1016_j_gaitpost_2021_10_029 crossref_primary_10_3389_fneur_2024_1363513 crossref_primary_10_3389_fnhum_2023_1325215 crossref_primary_10_1111_bcp_15205 crossref_primary_10_3171_2021_8_FOCUS21383 crossref_primary_10_3233_JPD_223274 crossref_primary_10_1002_mdc3_12915 crossref_primary_10_1016_j_prdoa_2021_100094 crossref_primary_10_1212_CPJ_0000000000000680 crossref_primary_10_3233_JPD_202411 crossref_primary_10_1002_trc2_12055 crossref_primary_10_2196_47882 crossref_primary_10_3233_JPD_202019 crossref_primary_10_1017_cts_2024_498 crossref_primary_10_1136_bmjno_2021_000173 crossref_primary_10_1136_bmjopen_2022_063767 crossref_primary_10_3390_s21082821 crossref_primary_10_1089_tmj_2021_0117 crossref_primary_10_1155_2021_5534282 crossref_primary_10_1177_1357633X221146819 crossref_primary_10_1212_NXG_0000000000200008 crossref_primary_10_1212_CPJ_0000000000000882 |
Cites_doi | 10.3233/JPD-140522 10.1016/0197-2456(87)90004-3 10.1056/NEJMc055540 10.1212/01.CPJ.0000437937.63347.5a 10.1016/j.parkreldis.2012.10.008 10.1177/014107689208500206 10.1200/JCO.2005.03.8976 10.1002/ana.20636 10.1001/jamaneurol.2013.123 10.1212/01.wnl.0000247740.47667.03 10.1002/mds.25357 10.1212/WNL.0b013e31822c9123 10.1016/S0197-2456(96)00236-X 10.1016/S0895-4356(99)00141-9 10.1002/mds.23145 10.1300/J010v19n02_01 10.1002/mds.25903 10.1002/mds.22340 10.1111/j.1468-0009.2011.00644.x 10.1097/JCP.0b013e3181d20912 10.1212/WNL.17.5.427 10.1002/mds.25814 10.1212/01.wnl.0000336652.05779.ea 10.1186/1744-859X-10-14 10.1016/j.parkreldis.2011.05.023 10.1001/jama.291.22.2720 10.1097/JCP.0b013e318192e4d7 10.1002/ana.21831 10.3109/00365548.2014.930966 10.1016/S0895-4356(01)00353-5 10.1016/S1470-2045(06)70576-9 10.1002/mds.24028 10.1016/S1353-8020(03)00066-X |
ContentType | Journal Article |
Copyright | IOS Press and the authors. All rights reserved IOS Press and the authors. All rights reserved 2015 |
Copyright_xml | – notice: IOS Press and the authors. All rights reserved – notice: IOS Press and the authors. All rights reserved 2015 |
DBID | AFRWT AAYXX CITATION CGR CUY CVF ECM EIF NPM 5PM |
DOI | 10.3233/JPD-150549 |
DatabaseName | Sage Journals GOLD Open Access 2024 CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: AFRWT name: Sage Journals GOLD Open Access 2024 url: http://journals.sagepub.com/ sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | E.R. Dorsey et al |
EISSN | 1877-718X |
EndPage | 515 |
ExternalDocumentID | PMC4923707 26406130 10_3233_JPD_150549 10.3233_JPD-150549 |
Genre | Journal Article |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GroupedDBID | --- 0R~ 4.4 53G ABDBF ABIVO ABJNI ACGFS ACPQW ACPRK ACUHS ADZMO AENEX AFRHK AFRWT AFYTF ALMA_UNASSIGNED_HOLDINGS EBD EJD GROUPED_DOAJ HZ~ IOS J8X MET MIO MV1 NGNOM O9- SAUOL SCNPE SFC AAYXX ACHEB CITATION CGR CUY CVF ECM EIF NPM 5PM |
ID | FETCH-LOGICAL-c476t-7612e42769a5ae0b26ea1c95ce1c0e100ec80d11ae75b8b5581a23cf4bac17f33 |
IEDL.DBID | AFRWT |
ISSN | 1877-7171 |
IngestDate | Thu Aug 21 13:17:23 EDT 2025 Thu Jan 02 23:04:54 EST 2025 Thu Apr 24 22:51:27 EDT 2025 Tue Jul 01 05:24:45 EDT 2025 Tue Jun 17 22:27:39 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Parkinson disease telemedicine |
Language | English |
License | This article is published online with Open Access and distributed under the terms of the Creative Commons Attribution Non-Commercial License. This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c476t-7612e42769a5ae0b26ea1c95ce1c0e100ec80d11ae75b8b5581a23cf4bac17f33 |
OpenAccessLink | https://journals.sagepub.com/doi/full/10.3233/JPD-150549?utm_source=summon&utm_medium=discovery-provider |
PMID | 26406130 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4923707 pubmed_primary_26406130 crossref_primary_10_3233_JPD_150549 crossref_citationtrail_10_3233_JPD_150549 sage_journals_10_3233_JPD_150549 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-09-14 |
PublicationDateYYYYMMDD | 2015-09-14 |
PublicationDate_xml | – month: 09 year: 2015 text: 2015-09-14 day: 14 |
PublicationDecade | 2010 |
PublicationPlace | London, England |
PublicationPlace_xml | – name: London, England – name: Netherlands – name: Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands |
PublicationTitle | Journal of Parkinson's disease |
PublicationTitleAlternate | J Parkinsons Dis |
PublicationYear | 2015 |
Publisher | SAGE Publications IOS Press |
Publisher_xml | – name: SAGE Publications – name: IOS Press |
References | Sharp (10.3233/JPD-150549_ref41) 2011; 10 10.3233/JPD-150549_ref42 10.3233/JPD-150549_ref23 Murthy (10.3233/JPD-150549_ref24) 2004; 291 Easterbrook (10.3233/JPD-150549_ref4) 1992; 85 Willis (10.3233/JPD-150549_ref32) 2011; 77 Nicoletti (10.3233/JPD-150549_ref34) 2003; 10 Hoehn (10.3233/JPD-150549_ref22) 1967; 17 Ross (10.3233/JPD-150549_ref10) 1999; 52 Dorsey (10.3233/JPD-150549_ref35) 2013; 28 Kobak (10.3233/JPD-150549_ref40) 2009; 29 Haidich (10.3233/JPD-150549_ref2) 2001; 54 Silberman (10.3233/JPD-150549_ref37) 2011; 89 Cubo (10.3233/JPD-150549_ref28) 2012; 27 Mills (10.3233/JPD-150549_ref9) 2006; 7 Ravina (10.3233/JPD-150549_ref38) 2010; 67 Valadas (10.3233/JPD-150549_ref12) 2011; 17 Lovato (10.3233/JPD-150549_ref1) 1997; 18 Achey (10.3233/JPD-150549_ref13) 2014; 29 Nasreddine (10.3233/JPD-150549_ref20) 2005; 53 Hunninghake (10.3233/JPD-150549_ref3) 1987; 8 Rocker (10.3233/JPD-150549_ref5) 2015; 5 Abdolahi (10.3233/JPD-150549_ref30) 2012; 19 Lesage (10.3233/JPD-150549_ref43) 2006; 354 Avis (10.3233/JPD-150549_ref8) 2006; 24 Trigo-Daporta (10.3233/JPD-150549_ref36) 2014; 46 Kobak (10.3233/JPD-150549_ref39) 2010; 30 Holden (10.3233/JPD-150549_ref6) 1993; 19 Goetz (10.3233/JPD-150549_ref19) 2008; 23 Dorsey (10.3233/JPD-150549_ref33) 2007; 68 Dorsey (10.3233/JPD-150549_ref14) 2013; 70 Karlawish (10.3233/JPD-150549_ref11) 2008; 71 Dorsey (10.3233/JPD-150549_ref29) 2010; 25 Tanner (10.3233/JPD-150549_ref31) 2014; 29 |
References_xml | – volume: 5 start-page: 55 year: 2015 ident: 10.3233/JPD-150549_ref5 article-title: Use of an online portal to faciilitate clinical trial recruitment: A preliminary analysis of Fox Trial Finder publication-title: J Parkinsons Dis doi: 10.3233/JPD-140522 – volume: 8 start-page: 6S year: 1987 ident: 10.3233/JPD-150549_ref3 article-title: Recruitment experience in clinical trials: Literature summary and annotated bibliography publication-title: Control Clin Trials doi: 10.1016/0197-2456(87)90004-3 – volume: 354 start-page: 422 year: 2006 ident: 10.3233/JPD-150549_ref43 article-title: LRRK2 G2019S as a cause of Parkinson’s disease in North African Arabs publication-title: New Engl J Med doi: 10.1056/NEJMc055540 – ident: 10.3233/JPD-150549_ref23 doi: 10.1212/01.CPJ.0000437937.63347.5a – volume: 53 start-page: 695 year: 2005 ident: 10.3233/JPD-150549_ref20 article-title: The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment publication-title: J Geriatr Psychiat – volume: 19 start-page: 218 year: 2012 ident: 10.3233/JPD-150549_ref30 article-title: Potential reliability and validity of a modified version ofthe Unified Parkinson’s Disease Rating Scale that could beadministered remotely publication-title: Parkinsonism Relat Disord doi: 10.1016/j.parkreldis.2012.10.008 – volume: 85 start-page: 71 year: 1992 ident: 10.3233/JPD-150549_ref4 article-title: Fate of research studies publication-title: J R Soc Med doi: 10.1177/014107689208500206 – volume: 24 start-page: 1860 year: 2006 ident: 10.3233/JPD-150549_ref8 article-title: Factors associated with participation in breast cancer treatment clinical trials publication-title: J Clin Oncol doi: 10.1200/JCO.2005.03.8976 – ident: 10.3233/JPD-150549_ref42 doi: 10.1002/ana.20636 – volume: 70 start-page: 565 year: 2013 ident: 10.3233/JPD-150549_ref14 article-title: Randomizedcontrolled clinical trial of “virtual house calls” for Parkinsondisease publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2013.123 – volume: 68 start-page: 384 year: 2007 ident: 10.3233/JPD-150549_ref33 article-title: Projected number of people withParkinson disease in the most populous nations, 2005 through 2030 publication-title: Neurol doi: 10.1212/01.wnl.0000247740.47667.03 – volume: 28 start-page: 261 year: 2013 ident: 10.3233/JPD-150549_ref35 article-title: Caring for the majority publication-title: Mov Disord doi: 10.1002/mds.25357 – volume: 77 start-page: 851 year: 2011 ident: 10.3233/JPD-150549_ref32 article-title: Neurologist care in Parkinson disease: A utilization, outcomes, and survival study publication-title: Neurol doi: 10.1212/WNL.0b013e31822c9123 – volume: 18 start-page: 328 year: 1997 ident: 10.3233/JPD-150549_ref1 article-title: Recruitment for controlled clinical trials: Literature summary and annotated bibliography publication-title: Control Clin Trials doi: 10.1016/S0197-2456(96)00236-X – volume: 52 start-page: 1143 year: 1999 ident: 10.3233/JPD-150549_ref10 article-title: Barriers to participation in randomised controlled trials:A systematic review publication-title: J Clin Epidemiol doi: 10.1016/S0895-4356(99)00141-9 – volume: 25 start-page: 1652 year: 2010 ident: 10.3233/JPD-150549_ref29 article-title: Increasing access to specialty care:A pilot, randomized controlled trial of telemedicine forParkinson’s disease publication-title: Mov Disord doi: 10.1002/mds.23145 – volume: 19 start-page: 1 year: 1993 ident: 10.3233/JPD-150549_ref6 article-title: The recruitment of research participants: A review publication-title: Soc Work Health Care doi: 10.1300/J010v19n02_01 – volume: 29 start-page: 871 year: 2014 ident: 10.3233/JPD-150549_ref13 article-title: The past, present, and future of telemedicinefor Parkinson’s disease publication-title: Mov Disord doi: 10.1002/mds.25903 – volume: 23 start-page: 2129 year: 2008 ident: 10.3233/JPD-150549_ref19 article-title: Movement Disorder Society-sponsored revision ofthe Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results publication-title: Mov Disord doi: 10.1002/mds.22340 – volume: 89 start-page: 599 year: 2011 ident: 10.3233/JPD-150549_ref37 article-title: Burdens on research imposed by institutional review boards: The state of the evidence and its implications for regulatory reform publication-title: Milbank Q doi: 10.1111/j.1468-0009.2011.00644.x – volume: 30 start-page: 193 year: 2010 ident: 10.3233/JPD-150549_ref39 article-title: Site versuscentralized raters in a clinical depression trial: Impact on patient selection and placebo response publication-title: J ClinPsychopharmacol doi: 10.1097/JCP.0b013e3181d20912 – volume: 17 start-page: 427 year: 1967 ident: 10.3233/JPD-150549_ref22 article-title: Parkinsonism: Onset, progression and mortality publication-title: Neurology doi: 10.1212/WNL.17.5.427 – volume: 29 start-page: 743 year: 2014 ident: 10.3233/JPD-150549_ref31 article-title: A practicalapproach to remote longitudinal follow-up of Parkinson’s disease:The FOUND study publication-title: Mov Disord doi: 10.1002/mds.25814 – volume: 71 start-page: 1883 year: 2008 ident: 10.3233/JPD-150549_ref11 article-title: Howredesigning AD clinical trials might increase study partners’willingness to participate publication-title: Neurol doi: 10.1212/01.wnl.0000336652.05779.ea – volume: 10 start-page: 14 year: 2011 ident: 10.3233/JPD-150549_ref41 article-title: The use of videoconferencing with patients with psychosis: A review of theliterature publication-title: Ann Gen Psychiatry doi: 10.1186/1744-859X-10-14 – volume: 17 start-page: 667 year: 2011 ident: 10.3233/JPD-150549_ref12 article-title: What motivatesParkinson’s disease patients to enter clinical trials? publication-title: Parkinson Relat Disord doi: 10.1016/j.parkreldis.2011.05.023 – volume: 291 start-page: 2720 year: 2004 ident: 10.3233/JPD-150549_ref24 article-title: Participation in cancerclinical trials: Race-, sex-, and age-based disparities publication-title: JAMA doi: 10.1001/jama.291.22.2720 – volume: 29 start-page: 82 year: 2009 ident: 10.3233/JPD-150549_ref40 article-title: Sources of unreliability in depression ratings publication-title: J Clin Psychopharmacol doi: 10.1097/JCP.0b013e318192e4d7 – volume: 67 start-page: 258 year: 2010 ident: 10.3233/JPD-150549_ref38 article-title: Local institutional review board (IRB) review of a multicentertrial: Local costs without local context publication-title: Ann Neurol doi: 10.1002/ana.21831 – volume: 46 start-page: 737 year: 2014 ident: 10.3233/JPD-150549_ref36 article-title: High-risk human papillomavirus in Galicia, Spain: Prevalence and evaluation of the sample representativeness publication-title: Scand J Infect Dis doi: 10.3109/00365548.2014.930966 – volume: 54 start-page: 877 year: 2001 ident: 10.3233/JPD-150549_ref2 article-title: Patterns of patient enrollment in randomized controlled trials publication-title: J Clin Epidemiol doi: 10.1016/S0895-4356(01)00353-5 – volume: 7 start-page: 141 year: 2006 ident: 10.3233/JPD-150549_ref9 article-title: Barriers to participation in clinical trialsof cancer: A meta-analysis and systematic review of patientreported factors publication-title: Lancet Oncol doi: 10.1016/S1470-2045(06)70576-9 – volume: 27 start-page: 308 year: 2012 ident: 10.3233/JPD-150549_ref28 article-title: Comparison of office-based versushome Web-based clinical assessments for Parkinson’s disease publication-title: Mov Disord doi: 10.1002/mds.24028 – volume: 10 start-page: 19 year: 2003 ident: 10.3233/JPD-150549_ref34 article-title: Prevalence of Parkinson’s disease: A door-to-door survey in rural Bolivia publication-title: Parkinsonism Relat Disord doi: 10.1016/S1353-8020(03)00066-X |
SSID | ssj0000516323 |
Score | 2.249828 |
Snippet | Abstract
Background: Fox Trial Finder is an online registry for individuals with and without Parkinson disease (PD) interested in participating in PD research.... Fox Trial Finder is an online registry for individuals with and without Parkinson disease (PD) interested in participating in PD research. However, distance or... Background: Fox Trial Finder is an online registry for individuals with and without Parkinson disease (PD) interested in participating in PD research. However,... |
SourceID | pubmedcentral pubmed crossref sage |
SourceType | Open Access Repository Index Database Enrichment Source Publisher |
StartPage | 505 |
SubjectTerms | Feasibility Studies Humans Internet Middle Aged Parkinson Disease - diagnosis Registries Surveys and Questionnaires Telemedicine - methods United States Videoconferencing |
Title | Feasibility of Virtual Research Visits in Fox Trial Finder |
URI | https://journals.sagepub.com/doi/full/10.3233/JPD-150549 https://www.ncbi.nlm.nih.gov/pubmed/26406130 https://pubmed.ncbi.nlm.nih.gov/PMC4923707 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LSyQxEC58XLyIi69xdWjYvXiIJp2k0wOC6LqNCIrI-Lg1nUwGB7RdZnoO_pv5LfPLrOoXjgh7TReku1Lp-ir1pQrgtx9kAxdbjE1UpJgaCscsdz3mvLCSexXLMqN7fRNd3qurJ_20BM_NXZhag5MjolXhG5U_a9rddBpNW1yGUh5f3V4wRDIY25xOi9e0Oudu2mnQCCWmp6-U03bEhHxnzb22ZVgNTaRxC6-eJXeP_fY8Bo0zkmU3OBEbwzDKEVU10y8TLviv1ml9JVR-YoWVjirZgPUaYQZnlUn8gCWfb8IJQr2aCPsevA2Dh9GYLo4EDfEOByajYhKM8vkMHdJ81ifDDBIqpjjegvvkb__PJasbJzCnTFQwg7DFK_zOXqYzz20Y-Uy4nsYFcNwLzr2L-UCIzBttY6t1LLJQuqGymRNmKOU2rORvud-FYCCVstZpa6zD2E_FiGh8rCPXowRuFnbgsFFH6uqq4tTc4iXF6IJUl6Lq0kp1HfjVyv6raml8K7VTKbOVQcxGqIN3wCyouRWgEtmLT_LRc1kqm8rPGW46ENCCpI11fTPt3v9FfsIawiVNbBGh9mGlGE_9AUKSwnbRms4vzpNubVVdWL65vf4AWgrjPg |
linkProvider | SAGE Publications |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1NT8JAEJ0oHPRiNH7hZxO9eKjudne7JfFCVIIIxBhQbk13u0QSUwzgwX_Db-GXOduWRgyJ13bSNm-nnTfdmTcAlyaOYh0ozE24z10-oNpVRFddbahixPCApTu67Y7f6PFmX_TzPm7bC5MjOLm2ZVX4ROnHOn-7mcfYTfP53kUSg2nNOpS5DVclKNfqL2_d4tcK-pnP0sFuNJDSxYSFZsKkfy6wFIqK-PO3NvJXgVcac-rbsJWTRaeWre4OrJlkF26RteU1rd_OaOC8Dse2B8RZ1NDhgclwOnGGyXyGsWU-61ofc-pWF3G8B736Q_eu4eYzEFzNpT91JTIQwz3pVyMRGaI830RUVwViqYmhhBgdkJjSyEihAiVEQCOP6QFXkaZywNg-lJJRYg7BiRnnSmmhpNKYxvEAyYkJhK-rdi828ipwtYAj1LlAuJ1T8RFiomChCxG6MIOuAheF7Wcmi7HS6iADs7BB-mUJBKmAXIK5MLBq18tnkuF7qnptleQkkRVw7IKEC0dZcduj_03OYaPRbbfC1mPn6Rg2kQUJWwRC-QmUpuMvc4pMY6rOcs_6AVVmzik |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LS8NAEB60BfEiiq_4DOjFQ3Q3u5tNwYuowWcpUh-3kN1ssCBpaevBf-Nv6S9zNkmDlYLXZEjCt7OZb3ZnvwE4NmmS6lBhbsID7vGMak8R3fK0oYoRw0NW7Og-toObZ373Jt6qpQt7FqZCcHRqy6rwi4qftZ3dgzSzM5z5jJ3dda48JDKY2ixCk3MMig1oXkRPr916eQV9LWBFczcaSulh0kJLcdI_D5gJR3UM-lsf-avIq4g70SqsVITRvShHeA0WTL4O58jcqrrWL7efuS-9oT0H4k7r6PDCqDceub188o3xZfLdtX7mRlYbcbgBz9F19_LGq_ogeJrLYOxJZCGG-zJoJSIxRPmBSahuCcRTE0MJMTokKaWJkUKFSoiQJj7TGVeJpjJjbBMaeT832-CmjHOltFBSaUzleIgExYQi0C27H5v4DpxM4Yh1JRJue1V8xJgsWOhihC4uoXPgqLYdlNIYc622SjBrG6RglkQQB-QMzLWBVbyevZP33gvla6smJ4l0wLUDEk-dZc5rd_43OYSlzlUUP9y273dhGYmQsHUglO9BYzz8NPtINsbqoHKsH3K6zzk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Feasibility+of+Virtual+Research+Visits+in%C2%A0Fox%C2%A0Trial+Finder&rft.jtitle=Journal+of+Parkinson%27s+disease&rft.au=Dorsey%2C+E.+Ray&rft.au=Wagner%2C+Joseph+D.&rft.au=Bull%2C+Michael+T.&rft.au=Rizzieri%2C+Ashley&rft.date=2015-09-14&rft.pub=IOS+Press&rft.issn=1877-7171&rft.eissn=1877-718X&rft.volume=5&rft.issue=3&rft.spage=505&rft.epage=515&rft_id=info:doi/10.3233%2FJPD-150549&rft_id=info%3Apmid%2F26406130&rft.externalDocID=PMC4923707 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1877-7171&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1877-7171&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1877-7171&client=summon |